Castle Biosciences, Inc. Stock
Equities
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.26 USD | -3.92% | -4.55% | +7.78% |
Financials (USD)
Sales 2024 * | 261M | Sales 2025 * | 261M | Capitalization | 642M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -56M | EV / Sales 2024 * | 1.51 x |
Net cash position 2024 * | 249M | Net cash position 2025 * | 201M | EV / Sales 2025 * | 1.69 x |
P/E ratio 2024 * |
-14.3
x | P/E ratio 2025 * |
-12.2
x | Employees | 638 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.98% |
Latest transcript on Castle Biosciences, Inc.
1 day | -3.92% | ||
1 week | -4.55% | ||
1 month | +10.29% | ||
3 months | +28.79% | ||
6 months | +16.36% | ||
Current year | +7.78% |
Managers | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Franklin Stokes
DFI | Director of Finance/CFO | 54 | 17-11-30 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Derek Maetzold
FOU | Founder | 62 | 07-08-31 |
Daniel Bradbury
CHM | Chairman | 62 | 12-08-31 |
G. Cole
BRD | Director/Board Member | 68 | 18-12-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.99% | 11 M€ | -6.03% | - | |
0.60% | 12 M€ | -.--% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 234 M€ | +8.48% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 23.26 | -3.92% | 208,285 |
24-05-30 | 24.21 | -1.22% | 184,216 |
24-05-29 | 24.51 | -0.08% | 206,448 |
24-05-28 | 24.53 | +0.66% | 179,661 |
24-05-24 | 24.37 | +2.65% | 130,508 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.78% | 642M | |
-3.43% | 12.45B | |
-3.17% | 8.22B | |
+31.98% | 5.67B | |
-10.03% | 4.11B | |
-59.94% | 2.68B | |
+11.23% | 2.68B | |
-5.14% | 2.37B | |
+18.91% | 2.06B | |
-7.56% | 1.8B |
- Stock Market
- Equities
- CSTL Stock